期刊文献+

靶向EZH2的shRNA表达对SW480细胞的抑制作用及5-Fu对其影响的研究 被引量:1

Inhibitive effect of EZH2-specific shRNA on SW480 cells and the impact of 5-FU
原文传递
导出
摘要 目的研究EZH2特异性shRNA对人结肠癌细胞株SW480细胞的抑制作用和化疗药物5-FU对其干预作用的影响。方法体外将EZH2特异性shRNA表达载体转染SW480细胞,RT-PCR和Western blotting检测细胞EZH2 mRNA及蛋白的表达,M TT法检测细胞增殖活性;将靶向EZH2的shRNA表达的SW480细胞接种于裸鼠,5-FU对其进行干预,RT-PCR检测瘤组织EZH2 mRNA的表达。结果与阴性对照组相比,基因沉默组EZH2 mRNA表达明显降低(P<0.01),EZH2蛋白表达明显降低(P<0.05);与空白对照组相比,基因沉默组细胞生长受到明显抑制(P<0.05);接种于裸鼠后,与正常组相比,5-FU基因沉默组与基因沉默组瘤组织体积、质量、EZH2 mRNA的表达均明显降低(P<0.01),与基因沉默组相比,5-FU基因沉默组EZH2 mRNA的表达明显降低(P<0.05)。结论靶向EZH2的shRNA表达在体外及体内均可显著抑制SW480细胞EZH2 mRNA和蛋白表达及细胞生长;5-FU能显著抑制体内EZH2基因沉默的SW480细胞EZH2 mRNA的表达。 Objective To investigate the inhibitive effect of EZH2-specific shRNA on human colon cancer cell line SW480 and the impact of 5-FU on this inhibitive effect.Methods SW480 cells were transfected with EZH2-specific shRNA in vitro,then EZH2 mRNA and protein expressions were detected with RT-PCR and Western blotting,and cell proliferation was examined with MTT.The EZH2-specific shRNA expressing SW480 cells were implanted to nude mice and treated with 5-FU.After that,the levels of EZH2 mRNA expressed by tumor tissues were measured with RT-PCR. Results Compared with that of the negative control group,the EZH2 mRNA expression (P〈0.01 )and protein expression (P〈0.05)of the gene-silencing group markedly decreased.The cell growth of the gene-silencing group was inhibited compared with that of the control group (P〈0.05 ).In nude mice,the tumor volume,tumor weight and EZH2 mRNA expression of the 5-FU gene-silencing group and of the gene-silencing group remarkably decreased com-pared with those of the normal group (P〈0.01).The EZH2 mRNA expression of the 5-FU gene-silencing group signifi-cantly decreased compared with that of the gene-silencing group (P〈0.05).Conclusion The EZH2-specific shRNA&nbsp;plays a significant inhibitive role on EZH2 mRNA and protein expressions in SW480 cells both in vitro and in vivo. 5-FU can significantly inhibit the EZH2 mRNA expression of EZH2-gene-silencing SW480 cells in vivo.
出处 《山东大学学报(医学版)》 CAS 北大核心 2014年第11期11-15,共5页 Journal of Shandong University:Health Sciences
基金 山东省自然科学基金(ZR2011HQ049) 济南市科技明星计划(201004055 20090208)
关键词 EZH2基因 RNA干扰 SW480细胞 5-FU EZH2 gene RNA interference SW480 cells 5-Fu
  • 相关文献

参考文献3

二级参考文献50

  • 1张孝卫,刘成霞,王兵,李铁军,张静,黄丽华,张尚忠.丁酸钠对小鼠大肠组织抑癌基因表达的影响[J].山东大学学报(医学版),2005,43(11):1083-1086. 被引量:1
  • 2Varamb',dly S, Dhanasekaran SM, Zhou M, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer [J]. Nature, 2002,419(6907):624-629.
  • 3Hanson RD, Hess JL, U BD, et al. Mammalian trithorax and poly- comb-group homologues are antagonistic regulators of homeotic de- velopment[J]. Proc Natl Acad Sci USA, 1999,96 (25): 14372-14377.
  • 4Jacobs J J, Van Lohuizen M. Polycomb repression: from cellular memory to cellular proliferation and cancer[J]. Biochim Biophys Acta, 2002,1602 (2):151-161.
  • 5Breuer RH, Snijders PJ, Smit EF, et al. Increased expression of the EZH2 polycomb group gene in BMI-l-positive neoplastic cells dur- ing bronchial carcinogenesis[J]. Neoplasia, 2004,6(6):736-743.
  • 6Weikert S, Christoph F, Kollermann J, et al. Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressive- ness and invasive potential of bladder carcinomas[J]. Int J Mol Med, 2005,16(2):349-353.
  • 7Arisan S, Buyuktuncer ED, Palavan-Unsal N, et al. Increased ex- pression of EZH2, a polycomb group protein, in bladder carcinoma[J]. Urol Int, 2005,75(3):252-257.
  • 8Cardoso C, Mignon C, Hetet G, et al. The human EZH2 gene: genomie organisation and revised mapping in 7q35 within the eritical region for malignant myeloid disorders[J]. Eur J Hum Genet, 2000,8 (3):174-180.
  • 9Tonini T, Bagella L, D'Andrilli G, et al. EZH2 reduces the ability of HDACl-dependent pRb2/pl30 transcriptiolal repression of cyclin A[J]. Oncogene, 2004-,23(28):4930-4937.
  • 10Collett K, Eide GE, Arnes J, et al. Expression of enhancer of zeste homologne 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast eancer [J]. Clin Cancer Res, 2006,12(4):1168-1174.

共引文献4

同被引文献13

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部